Abbrea Capital, LLC Danaher Corp Transaction History

Abbrea Capital, LLC

$755 Million
Q2 2024

A detailed history of Abbrea Capital, LLC transactions in Danaher Corp stock. As of the latest transaction made, Abbrea Capital, LLC holds 5,640 shares of DHR stock, worth $1.33 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

5,640

Previous 5,768 2.22%

Holding current value

$1.33 Million

Previous $1.44 Million 2.15%

% of portfolio

0.19%

Previous 0.19%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$235.51 - $267.98 $30,145 - $34,301	-128 Reduced 2.22%	5,640 $1.41 Million
Q1 2024 May 07, 2024	BUY	$224.58 - $256.19 $11,453 - $13,065	51 Added 0.89%	5,768 $1.44 Million
Q4 2023 Feb 02, 2024	SELL	$185.1 - $233.13 $18,510 - $23,313	-100 Reduced 1.72%	5,717 $1.32 Million
Q3 2023 Oct 31, 2023	SELL	$233.08 - $265.59 $23,308 - $26,558	-100 Reduced 1.69%	5,817 $1.44 Million
Q2 2023 Aug 01, 2023	BUY	$224.99 - $256.14 $17,099 - $19,466	76 Added 1.3%	5,917 $1.42 Million
Q1 2023 May 11, 2023	BUY	$239.75 - $277.0 $11,987 - $13,850	50 Added 0.86%	5,841 $1.47 Million
Q4 2022 Feb 08, 2023	SELL	$241.42 - $282.29 $15,209 - $17,784	-63 Reduced 1.08%	5,791 $1.54 Million
Q3 2022 Nov 03, 2022	BUY	$247.06 - $1507.4 $8,400 - $51,251	34 Added 0.58%	5,854 $1.51 Million
Q2 2022 Aug 02, 2022	SELL	$237.11 - $299.66 $4,742 - $5,993	-20 Reduced 0.34%	5,820 $1.48 Million
Q1 2022 May 11, 2022	BUY	$257.27 - $315.76 $9,004 - $11,051	35 Added 0.6%	5,840 $1.72 Million
Q4 2021 Feb 04, 2022	BUY	$292.08 - $329.01 $167,946 - $189,180	575 Added 10.99%	5,805 $1.91 Million
Q3 2021 Nov 04, 2021	BUY	$272.21 - $332.43 $98,812 - $120,672	363 Added 7.46%	5,230 $1.59 Million
Q2 2021 Aug 04, 2021	BUY	$225.08 - $271.69 $64,147 - $77,431	285 Added 6.22%	4,867 $1.31 Million
Q1 2021 May 13, 2021	BUY	$212.38 - $245.9 $55,431 - $64,179	261 Added 6.04%	4,582 $1.03 Million
Q4 2020 Jan 21, 2021	BUY	$212.5 - $245.46 $10,412 - $12,027	49 Added 1.15%	4,321 $961,000
Q3 2020 Oct 20, 2020	BUY	$177.16 - $215.33 $46,770 - $56,847	264 Added 6.59%	4,272 $921,000
Q2 2020 Aug 11, 2020	SELL	$128.7 - $176.83 $23,423 - $32,183	-182 Reduced 4.34%	4,008 $709,000
Q1 2020 Apr 29, 2020	BUY	$121.39 - $169.05 $7,647 - $10,650	63 Added 1.53%	4,190 $581,000
Q4 2019 Feb 11, 2020	BUY	$133.47 - $153.48 $30,698 - $35,300	230 Added 5.9%	4,127 $634,000
Q3 2019 Nov 07, 2019	BUY	$135.4 - $146.47 $76,501 - $82,755	565 Added 16.96%	3,897 $564,000
Q2 2019 Jul 31, 2019	BUY	$124.88 - $143.73 $44,207 - $50,880	354 Added 11.89%	3,332 $477,000
Q1 2019 May 08, 2019	BUY	$97.62 - $132.29 $19,524 - $26,458	200 Added 7.2%	2,978 $394,000
Q4 2018 Feb 05, 2019	BUY	$94.85 - $109.54 $11,382 - $13,144	120 Added 4.51%	2,778 $287,000
Q2 2018 Aug 08, 2018	BUY	$96.1 - $103.24 $255,433 - $274,411	2,658 New	2,658 $263,000

Others Institutions Holding DHR

# of Institutions

2,508

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abbrea Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abbrea Capital, LLC with notifications on news.

Account

Abbrea Capital, LLC Danaher Corp Transaction History